Trial Profile
The efficacy of tolvaptan for patients with chronic kidney disease and chronic heart failure
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Chronic heart failure; Renal failure
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 21 Mar 2018 New trial record